A major gift to SIU School of Medicine will transform the health care of people throughout Illinois and beyond. Springfield couple Dale and Deborah Smith donated a substantial financial gift to the Center for Alzheimer’s Disease and Related Disorders at SIU Medicine to expand research, enhance programming and improve care for people with Alzheimer’s disease and assist their caregivers. The center will now be named the Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at SIU Medicine. The center provides clinical care, research and community programs throughout Illinois

Simmons Cancer Institute at SIU’s release of butterflies is a beautiful way to honor the living and celebrate the memory of loved ones by sponsoring a butterfly in their names. The ceremony will include the public reading of the names of those being honored and/or remembered, music, inspirational readings, and a magnificent release of butterflies. Seating is limited and masks are required. The emergence of a butterfly is a sign of renewal of life and its flight symbolizes freedom and happiness. Your gift of $25 per butterfly/name benefits Simmons Cancer Institute at SIU. To sponsor, go online

Right now, an estimated 5.8 million Americans have Alzheimer's disease. As the global population continues to age, more people will be affected by this neurodegenerative disorder. Sadly, Alzheimer’s could impact up to 14 million Americans by 2050 if no cure is found. As leaders and innovators in academic medicine, clinical care and scientific research, SIU Medicine is proud to join a global community of providers and researchers who are striving to make a difference in the lives of people affected by this condition. Thanks to a generous donation, the Dale and Deborah Smith Center for Alzheimer

A major gift to Southern Illinois University School of Medicine will transform the health care of people throughout Illinois and beyond. Dale and Deborah Smith recently donated a substantial financial gift to the Center for Alzheimer’s Disease and Related Disorders at SIU Medicine to expand research, enhance programming and improve care for people with Alzheimer’s disease and assist their caregivers. The center will now be named the Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at SIU Medicine. The Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at

A major gift to Southern Illinois University School of Medicine will transform the health care of people throughout Illinois and beyond. Dale and Deborah Smith recently donated a substantial financial gift to the Center for Alzheimer’s Disease and Related Disorders at SIU Medicine to expand research, enhance programming and improve care for people with Alzheimer’s disease and assist their caregivers. The center will now be named the Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at SIU Medicine. The Dale and Deborah Smith Center for Alzheimer’s Research and Treatment at

Resources for farmers and farm families in Illinois

Frequently Asked Questions Are pregnant and breastfeeding women allowed to get the COVID-19 vaccine? Yes. The Center for Disease Control (CDC), the American College of Obstetricians and Gynecologists (ACOG, the primary professional society of US OB/GYNs), the Society for Maternal Fetal Medicine (SMFM), and the American Society for Reproductive Medicine (ASRM) have all recommended offering the COVID-19 vaccine to women who are trying to get pregnant, currently pregnant or breastfeeding. It is important for pregnant women to be given the chance to get vaccinated in part because pregnant women

SIU Medicine is recruiting patients with early-stage Parkinson’s disease to study a new drug that could become a potential treatment for the debilitating condition. Parkinson's disease (PD) is a nervous system disorder that affects movement, causing slowness, stiffness, tremors and walking and balance problems. Over time, patients diagnosed with PD experience a worsening of their symptoms. In the early stages of Parkinson’s disease, symptoms may be mild and the diagnosis can be easily missed. The symptoms include: Slowed movement, also known as bradykinesia (difficulties getting out of a chair

Do you suffer from Post-Traumatic Stress Disorder (PTSD) or know someone who does? SIU School of Medicine has launched a clinical trial to study the safety and efficacy of an investigational drug for PTSD. Local researchers are evaluating an investigational drug that has received FDA approval for schizophrenia and as an adjunctive therapy for major depressive disorder. In the new study, doctors want to evaluate the investigational drug in combination with the drug sertraline for treatment of PTSD. Jeffrey Bennett, MD , is associate professor of psychiatry at SIU School of Medicine and the